ArticleNanomaterials (Basel, Switzerland)2023
Ostwald Ripening and Antibacterial Activity of Silver Nanoparticles Capped by Anti-Inflammatory Ligands.
Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Glucose-Responsive Nanomedicine in Diabetes Therapy: Emerging Advances and Clinical Prospects.Journal of functional biomaterials · 2026Review
- Advanced Antibacterial Nanocomposite Fibers for Biomedical Applications.Pharmaceutics · 2026Article
- Engineering Design Strategies for Boosting Photocatalytic Activity: Theory-to-Data-Driven Perspective.Materials (Basel, Switzerland) · 2026Review
- A comparative evaluation of green colloidal silver variants for enhanced stability and bioactivity.Scientific reports · 2025Article
- Silver Nanoparticles for Biosensing and Drug Delivery: A Mechanical Study on DNA Interaction.Biosensors · 2025Article
- Efficient and Rapid Microfluidics Production of Bio-Inspired Nanoparticles Derived fromPharmaceutics · 2025Article
- Three-Dimensional Evaluation of the Cytotoxicity and Antibacterial Properties of Alpha Lipoic Acid-Capped Silver Nanoparticle Constructs for Oral Applications.Nanomaterials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Silver nanoparticles (AgNPs) have been extensively studied during recent decades as antimicrobial agents. However, their stability and antibacterial activity over time have yet to be sufficiently studied. In this work, AgNPs were coated with different stabilizers (naproxen and diclofenac and 5-chlorosalicylic acid) in different concentrations. The suspensions of nanostructures were characterized by transmission electron microscopy, UV-Vis and FT-IR spectroscopic techniques. The antibacterial activity as a function of time was determined through microbiological studies against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.